Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/36573
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorAguilar Jiménez, Wbeimar-
dc.contributor.authorZapata Builes, Wildeman-
dc.contributor.authorRugeles López, María Teresa-
dc.date.accessioned2023-09-06T16:43:21Z-
dc.date.available2023-09-06T16:43:21Z-
dc.date.issued2016-
dc.identifier.citationAguilar-Jimenez W, Zapata W, Rugeles MT. Antiviral molecules correlate with vitamin D pathway genes and are associated with natural resistance to HIV-1 infection. Microbes Infect. 2016 Jul-Aug;18(7-8):510-6. Epub 2016 Apr 12. PMID: 27083474.spa
dc.identifier.issn1286-4579-
dc.identifier.issn1769-714X-
dc.identifier.urihttps://hdl.handle.net/10495/36573-
dc.description.abstractABSTRACT: The relationship between the immunomodulatory effects of Vitamin D (VitD) and the expression of anti-HIV-1 molecules has not been explored in HIV-1-exposed seronegative individuals (HESNs). Higher mRNA levels of cathelicidin and HAD-4 in oral-mucosa and peripheral-blood, along with higher CYP24A1 mRNA in vaginal-mucosa and lower TLR2 mRNA in endocervical-mucosa were found in HESNs compared to non exposed controls. Furthermore, the mRNA of anti-HIV molecules Elafin, TRIM5, Cathelicidin, HAD-4 and RNase7, previously associated with natural resistance to HIV-1 infection, positively correlated with the mRNA expression of VDR in HESNs, suggesting the potential participation of VitD in natural resistance to HIV-1.spa
dc.format.extent7spa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherElsevierspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.titleAntiviral molecules correlate with vitamin D pathway genes and are associated with natural resistance to HIV-1 infectionspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupInmunovirologíaspa
dc.identifier.doij.micinf.2016.03.015_-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
oaire.citationtitleMicrobes and Infectionspa
oaire.citationstartpage510spa
oaire.citationendpage516spa
oaire.citationvolume18spa
oaire.citationissue7-8spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by-nc-nd/4.0/spa
dc.publisher.placeParís, Franciaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsVIH-1-
dc.subject.decsHIV-1-
dc.subject.decsAntivirales-
dc.subject.decsAntiviral Agents-
dc.subject.decsVitamina D-
dc.subject.decsVitamin D-
dc.subject.decsExposición a Riesgos Ambientales-
dc.subject.decsEnvironmental Exposure-
dc.subject.decsPerfilación de la Expresión Génica-
dc.subject.decsGene Expression Profiling-
dc.subject.decsPersona de Mediana Edad-
dc.subject.decsMiddle Aged-
dc.description.researchgroupidCOL0012444spa
dc.relation.ispartofjournalabbrevMicrobes Infect.spa
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
AguilarWbeimar_2016_AntiviralMoleculesCorrelateVitaminD (1).pdfArtículo de Investigación856.06 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons